“Brentuximab is chemotherapy and targeted therapy combination drug used to treat Hodgkin’s lymphoma, anaplastic large cell lymphoma, and certain types of peripheral T-cell lymphomas.”
Category:
B
-
-
-
Bevacizumab is a targeted therapy drug used to treat metastatic colorectal cancer, metastatic lung cancer, brain tumour, metastatic kidney cancer, liver cancer, ovarian cancer, and cervical cancer.